Literature DB >> 31122802

The influence of the brain-gut axis in inflammatory bowel disease and possible implications for treatment.

David J Gracie1, P John Hamlin2, Alexander C Ford3.   

Abstract

Brain-gut interactions affect psychological wellbeing and symptom reporting in functional gastrointestinal disorders; the presence of anxiety or depression is associated with the development of new-onset gastrointestinal symptoms, and the presence of gastrointestinal symptoms is associated with the development of psychological disorders de novo. In inflammatory bowel diseases (IBD), the reporting of irritable bowel syndrome (IBS)-type symptoms by patients with quiescent disease is common, and is associated with psychological disorders, impaired quality of life, and increased health-care use. In IBD, data from observational studies suggest that psychological disorders might be associated with relapse of disease activity, and that inflammatory activity is associated with the development of new psychological disorders, as has been described for functional gastrointestinal disorders such as IBS and functional dyspepsia. The brain-gut axis provides the physiological link between the CNS and gastrointestinal tract that might facilitate these relationships. In IBS, treatments targeting disordered brain-gut axis activity, including psychological therapies and antidepressants, might lead to improved symptoms and quality of life. However, in IBD, the benefit of these treatments is less certain because of a scarcity of interventional studies. Despite the scarcity of trials, observational data suggest that the effect of disordered brain-gut axis activity in IBD is substantial, and scope remains for further well designed trials of psychological therapies and antidepressants, particularly in the subset of patients who have coexistent psychological disorders, or in those who report IBS-type symptoms. Integrating these treatments into a biopsychosocial model of care has the potential to improve both psychological wellbeing and quality of life in some patients with IBD, reducing health-care use and altering the natural history of disease.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31122802     DOI: 10.1016/S2468-1253(19)30089-5

Source DB:  PubMed          Journal:  Lancet Gastroenterol Hepatol


  38 in total

1.  Roe-inspired stem cell microcapsules for inflammatory bowel disease treatment.

Authors:  Guopu Chen; Fengyuan Wang; Min Nie; Hui Zhang; Han Zhang; Yuanjin Zhao
Journal:  Proc Natl Acad Sci U S A       Date:  2021-10-26       Impact factor: 11.205

Review 2.  The Microbiota-Gut-Brain Axis in Depression: The Potential Pathophysiological Mechanisms and Microbiota Combined Antidepression Effect.

Authors:  Fangyuan Zhu; Huaijun Tu; Tingtao Chen
Journal:  Nutrients       Date:  2022-05-16       Impact factor: 6.706

3.  Exploration of the Common Gene Characteristics and Molecular Mechanism of Parkinson's Disease and Crohn's Disease from Transcriptome Data.

Authors:  Haoran Zheng; Xiaohang Qian; Wotu Tian; Li Cao
Journal:  Brain Sci       Date:  2022-06-13

4.  Optogenetic activation of local colonic sympathetic innervations attenuates colitis by limiting immune cell extravasation.

Authors:  Maya Schiller; Hilla Azulay-Debby; Nadia Boshnak; Yehezqel Elyahu; Ben Korin; Tamar L Ben-Shaanan; Tamar Koren; Maria Krot; Fahed Hakim; Asya Rolls
Journal:  Immunity       Date:  2021-04-30       Impact factor: 31.745

5.  Influence of the COVID-19 Outbreak on Disease Activity and Quality of Life in Inflammatory Bowel Disease Patients.

Authors:  Chiara Conti; Ilenia Rosa; Luigia Zito; Laurino Grossi; Konstantinos Efthymakis; Matteo Neri; Piero Porcelli
Journal:  Front Psychiatry       Date:  2021-04-22       Impact factor: 4.157

6.  Psychosomatic Disorders in Patients with Gastrointestinal Diseases: Single-Center Cross-Sectional Study of 1186 Inpatients.

Authors:  Lijuan Feng; Zichun Li; Xuerong Gu; Jiahui Jiang; Xiaowei Liu
Journal:  Gastroenterol Res Pract       Date:  2021-05-01       Impact factor: 2.260

7.  Altered structural covariance and functional connectivity of the insula in patients with Crohn's disease.

Authors:  Shuming Zhang; Fenrong Chen; Jiayu Wu; Chengxiang Liu; Guang Yang; Ruiqing Piao; Bowen Geng; Ke Xu; Peng Liu
Journal:  Quant Imaging Med Surg       Date:  2022-02

8.  Association between antidepressant medication use and steroid dependency in patients with ulcerative colitis: a population-based study.

Authors:  Jonathan Blackwell; Christopher Alexakis; Sonia Saxena; Hanna Creese; Alex Bottle; Irene Petersen; Matthew Hotopf; Richard C G Pollok
Journal:  BMJ Open Gastroenterol       Date:  2021-05

Review 9.  Tryptophan-kynurenine metabolism: a link between the gut and brain for depression in inflammatory bowel disease.

Authors:  Li-Ming Chen; Chun-Hui Bao; Yu Wu; Shi-Hua Liang; Di Wang; Lu-Yi Wu; Yan Huang; Hui-Rong Liu; Huan-Gan Wu
Journal:  J Neuroinflammation       Date:  2021-06-14       Impact factor: 8.322

10.  Impact of the Coronavirus Disease Pandemic on Health-Related Quality of Life of Patients with Inflammatory Bowel Disease.

Authors:  Emma Paulides; Annelieke Pasma; Nicole S Erler; Rachel L A van Eijk; Annemarie C de Vries; C Janneke van der Woude
Journal:  Dig Dis Sci       Date:  2021-06-28       Impact factor: 3.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.